tiprankstipranks
Trending News
More News >
Lion Corporation (JP:4912)
:4912
Advertisement

Lion (4912) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4912

Lion

(OTC:4912)

Rating:69Neutral
Price Target:
¥1,720.00
▲(9.24% Upside)
Lion's overall stock score is driven by strong financial performance, particularly a robust balance sheet and stable profitability. However, the recent decline in revenue and free cash flow growth poses risks. Technical analysis indicates cautious sentiment, with the stock trading below key moving averages. Valuation is fair, but not compelling enough to offset the financial and technical concerns.

Lion (4912) vs. iShares MSCI Japan ETF (EWJ)

Lion Business Overview & Revenue Model

Company DescriptionLion Corporation (4912) is a leading Japanese manufacturer in the personal care, healthcare, and household products sectors. The company is renowned for its development and production of a wide range of products including oral care items like toothpaste and toothbrushes, skincare solutions, and laundry detergents. Lion Corporation is committed to enhancing the quality of life through its innovative and environmentally sustainable products.
How the Company Makes MoneyLion Corporation generates its revenue through the sale of its diverse range of personal care, healthcare, and household products. The company’s key revenue streams include its oral care products, such as toothpaste and mouthwash, which hold a significant market share in Japan. Additionally, its laundry detergents and cleaning products contribute substantially to its income. Lion Corporation also benefits from strategic partnerships and collaborations that enhance its distribution network and expand its market reach, particularly in Asia. The company invests in research and development to innovate and maintain its competitive edge, which is crucial for sustaining its revenue growth.

Lion Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted an increase in net sales and profits, driven by effective price revisions and structural reforms. However, challenges such as impairment losses, a decline in domestic sales, and a slowdown in certain overseas markets were also noted. The partnership with Japan Activation Capital is a strategic move to bolster future growth.
Q3-2024 Updates
Positive Updates
Increased Net Sales and Profits
Net sales were JPY 301.1 billion, up 1.7% year-on-year. Core operating income was JPY 18.6 billion, an increase of JPY 6 billion year-on-year.
EBITDA Growth
EBITDA was JPY 32.5 billion, up JPY 6.4 billion year-on-year, with an EBITDA margin increase of 2 percentage points to 10.8%.
Price Revision and Profit Structure Reform
Price revisions led to JPY 2.8 billion in increased profits. The company plans to achieve JPY 4 billion in price revisions by the end of the year.
Overseas Business Performance
Double-digit growth in overseas sales. Thailand grew 1.1%, Malaysia 8.2%, China 9.2%, and South Korea 5.2% in local currency terms.
Partnership with Japan Activation Capital
Announced a partnership with Japan Activation Capital to support management policy strategy and enhance execution speed.
Negative Updates
Impairment Loss on Domestic Facilities
Impairment loss of approximately JPY 6.2 billion due to streamlining of domestic home care production facilities.
Challenges in Fabric Care
Fabric Care business has been in the red due to CapEx and promotion costs, but structural reform is expected to return it to profitability.
Sales Decline in Domestic Consumer Products
Domestic consumer product sales declined by 4.3% due to a reactionary downturn from a previous year's new product launch.
Moderate Growth in Overseas Markets
Growth has slowed down in Southeast and South Asia and Northeast Asia compared to the first half of the year.
Economic Slowdown in China
Chinese economy showing signs of slowing, impacting existing stores, though new distribution networks are expanding.
Company Guidance
In the earnings call for Q3 2024, Lion Corporation reported a 1.7% increase in net sales to JPY 301.1 billion, with a core operating income rise of JPY 6 billion year-on-year, reaching JPY 18.6 billion. The EBITDA was JPY 32.5 billion, up by JPY 6.4 billion, with a margin increase of 2 percentage points to 10.8%. Despite an impairment loss of JPY 6.2 billion due to domestic production facility streamlining, the company maintained its full-year forecast, attributing the resilient performance to price revisions and cost reductions, specifically mentioning a JPY 2.8 billion price revision impact and a total cost reduction of JPY 2.2 billion. The consumer product sales in Japan fell by 4.3%, whereas overseas sales showed sustained double-digit growth. The company plans further asset sales in Q4 to support ongoing structural reforms, aiming for a total shareholder return ratio of 91.9% with a dividend set at JPY 27 per share.

Lion Financial Statement Overview

Summary
Lion demonstrates a stable financial performance with steady revenue growth and strong profitability margins. The balance sheet is solid with low leverage and high equity, providing a stable foundation. While cash flow generation has faced challenges, the company's efficient operations and strong asset base mitigate potential risks.
Income Statement
75
Positive
The income statement shows a consistent growth trajectory in revenue, with a TTM revenue growth rate of 0.31% compared to the previous period. The gross profit margin for TTM is strong at 45.54%, indicating effective cost management. The net profit margin for TTM is 5.23%, which is stable but slightly lower than historical highs, suggesting room for improvement in profitability. EBIT and EBITDA margins are healthy, indicating operational efficiency.
Balance Sheet
80
Positive
The balance sheet reflects a solid financial position with a low debt-to-equity ratio of 0.10, highlighting conservative leverage. The equity ratio is robust at 62.37%, suggesting strong asset backing. Return on equity for TTM is 7.50%, which is satisfactory but could be improved to enhance shareholder returns. Overall, the balance sheet indicates stability and financial strength.
Cash Flow
70
Positive
The cash flow statement reveals a decline in free cash flow growth rate, with a decrease of 21.52% from the previous period, indicating potential challenges in cash generation. However, the operating cash flow to net income ratio is strong at 1.78, showing efficient conversion of net income into cash. The free cash flow to net income ratio stands at 0.93, reflecting the company's capacity to generate free cash relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue413.77B412.94B402.77B389.87B366.23B355.35B
Gross Profit188.99B188.78B180.60B174.61B179.10B179.87B
EBITDA49.88B49.55B43.42B47.31B46.06B56.37B
Net Income20.88B21.20B14.62B21.94B23.76B29.87B
Balance Sheet
Total Assets468.81B497.17B486.36B469.28B428.02B435.50B
Cash, Cash Equivalents and Short-Term Investments80.78B102.24B85.53B101.08B97.25B121.53B
Total Debt29.31B29.74B30.34B32.17B8.37B8.12B
Total Liabilities151.52B181.47B188.23B190.11B163.01B190.65B
Stockholders Equity295.97B293.72B280.32B264.25B251.57B231.72B
Cash Flow
Free Cash Flow13.90B25.60B5.08B18.82B-23.63B13.80B
Operating Cash Flow36.51B43.66B30.07B41.96B19.30B40.73B
Investing Cash Flow-17.23B-7.66B-34.79B-19.54B-34.18B-19.87B
Financing Cash Flow-11.70B-21.20B-11.76B-19.82B-10.22B-9.14B

Lion Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1574.50
Price Trends
50DMA
1520.72
Positive
100DMA
1577.15
Negative
200DMA
1652.16
Negative
Market Momentum
MACD
23.64
Positive
RSI
50.18
Neutral
STOCH
3.30
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4912, the sentiment is Negative. The current price of 1574.5 is below the 20-day moving average (MA) of 1591.02, above the 50-day MA of 1520.72, and below the 200-day MA of 1652.16, indicating a neutral trend. The MACD of 23.64 indicates Positive momentum. The RSI at 50.18 is Neutral, neither overbought nor oversold. The STOCH value of 3.30 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4912.

Lion Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$427.32B20.857.29%1.84%1.29%4.72%
63
Neutral
$20.44B14.73-2.84%3.14%2.04%-6.12%
$2.68B34.105.72%1.89%
$552.33M43.126.66%1.13%
$1.94B45.023.99%5.45%
$3.97B14.5413.33%1.27%
70
Outperform
¥156.95B20.64
4.90%-1.63%1.81%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4912
Lion
1,574.50
116.45
7.99%
KBYPF
Kobayashi Pharmaceutical Co
36.02
-1.89
-4.99%
MIOFF
Milbon Co
27.62
0.58
2.14%
PORBF
Pola Orbis Holdings
8.81
-0.77
-8.04%
RPHCF
Rohto Pharmaceutical Co
14.72
-9.66
-39.62%
JP:4928
Noevir Holdings Co., Ltd.
4,595.00
-780.38
-14.52%

Lion Corporate Events

Lion Corporation Reports Stable First Half 2025 Financial Results with Increased Dividends
Aug 7, 2025

Lion Corporation’s financial results for the first half of 2025 show a slight increase in net sales and operating profit, despite a decrease in profit before tax and profit attributable to owners. The company’s core operating income improved significantly, indicating strong regular business performance. The financial position remains stable with a slight increase in total equity, and the company has announced an increase in cash dividends per share, reflecting confidence in future earnings.

The most recent analyst rating on (JP:4912) stock is a Buy with a Yen1750.00 price target. To see the full list of analyst forecasts on Lion stock, see the JP:4912 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 29, 2025